Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP310687.RAqjP76TDIDg_ZVrmADwQ1OrbWezncA6AC3ECPA0x4cu4130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310687.RAqjP76TDIDg_ZVrmADwQ1OrbWezncA6AC3ECPA0x4cu4130_provenance.
• NP155522.RAeS3BXxIvIYlnDhykJ5KwGSgg9MJBnMdb3PYoJPqF8oo130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155522.RAeS3BXxIvIYlnDhykJ5KwGSgg9MJBnMdb3PYoJPqF8oo130_provenance.
• assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP395987.RA5I-albvkIaQUD6ZObTGzWslrVL9vr5lPWC0BgCG-dPo130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395987.RA5I-albvkIaQUD6ZObTGzWslrVL9vr5lPWC0BgCG-dPo130_provenance.
• NP250936.RA_Ol-meQrsJJ9xNyZWi3Y6pefy_kHjbw53x8aRKwjalc130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250936.RA_Ol-meQrsJJ9xNyZWi3Y6pefy_kHjbw53x8aRKwjalc130_provenance.
• NP330485.RADvI3HrtSG0NKqeghuxMstNfKCGPc_fXBApnRvj_z_wQ130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330485.RADvI3HrtSG0NKqeghuxMstNfKCGPc_fXBApnRvj_z_wQ130_provenance.
• NP250998.RAdY7MpxQcaA72x8UQxyLvuKxi6uTssrufEJy74Fi-bP0130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250998.RAdY7MpxQcaA72x8UQxyLvuKxi6uTssrufEJy74Fi-bP0130_provenance.
• NP788718.RA9SQXvXuLh-NCdH4JBGCg2SWTfH9l2o9dU52tBDLZZb0130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788718.RA9SQXvXuLh-NCdH4JBGCg2SWTfH9l2o9dU52tBDLZZb0130_provenance.
• assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP330487.RAd4sF7-LdJsLMOYDOefZC7KA5aqQfbpfnZ7rdwCStXb4130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330487.RAd4sF7-LdJsLMOYDOefZC7KA5aqQfbpfnZ7rdwCStXb4130_provenance.
• NP330492.RAXSGyRoee1AumL4k_3vUTMYAgncA5_UU1PWMftADlV-o130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330492.RAXSGyRoee1AumL4k_3vUTMYAgncA5_UU1PWMftADlV-o130_provenance.
• assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP788714.RAMaXKSzt21a8lT7kjtuXmVszes2kNSPtEXsEcbGlTgO0130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788714.RAMaXKSzt21a8lT7kjtuXmVszes2kNSPtEXsEcbGlTgO0130_provenance.
• NP330484.RAMkzO_aIlNoSEd8tCn3wGGzukD7Tykzy-NaDkBgDtPVI130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330484.RAMkzO_aIlNoSEd8tCn3wGGzukD7Tykzy-NaDkBgDtPVI130_provenance.
• NP330493.RAHu1cp4dTrJWRGr53-Zd2mJDGMibb47-jLjQ-8IkSkXc130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330493.RAHu1cp4dTrJWRGr53-Zd2mJDGMibb47-jLjQ-8IkSkXc130_provenance.
• NP330488.RAnf6eJ18-0r45gPuw22TSZWvZ4kU7SNAfJL8TamGtv-Y130_assertion description "[We examined ARA70 and AR expression in 20 HER2-positive (overexpressing) and 21 HER2-negative cases of breast invasive ductal carcinoma (IDC) to determine the relationship between loss of ARA70 and/or AR with HER2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330488.RAnf6eJ18-0r45gPuw22TSZWvZ4kU7SNAfJL8TamGtv-Y130_provenance.